Registry of Lobbyists
Version 15 of 17 (2006-09-14 to 2007-04-13) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Organization: |
Canadian Healthcare Association / Association canadienne des soins de santé
17 YORK STREET OTTAWA, ON K1N 9J6 Canada |
||||
| Telephone number: | 613-241-8005 | ||||
| Fax number: | 613-241-5055 | ||||
| Responsible officer name and position during the period of this registration: | SHARON SHOLZBERG-GRAY, PRESIDENT AND CEO | ||||
| Description of the organization's activities: | CHA is a leader in developing, and advocating for, health policy solutions that meet the needs of Canadians. CHA's distance learning programs, conferences and publishing services contribute to this national leadership. CHA and its members are committed to a publicly-funded health system that provides access to a continuum of comparable health services throughout Canada. | ||||
| Organization's membership or classes of membership: | CHA's members are Canada's provincial and territorial hospital and health organizations representing a broad continuum of care including acute care, home and community care, long term care, public health, mental health, palliative care, addiction services, children, youth and family services and housing services. | ||||
| Was the organization funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | Yes | ||||
| End date of the organization's last completed financial year: | 2005-12-31 | ||||
|
|||||
| Name: | Garnet Burns |
| Position title: | Board Chair |
| Public offices held: | No |
| Name: | Lynda Cranston |
| Position title: | Board Chair Elect |
| Public offices held: | No |
| Name: | DENISE DESAUTELS |
| Position title: | DIRECTOR, POLICY AND COMMUNICATIONS |
| Public offices held: | Yes |
| Name: | DELLA FAULKNER |
| Position title: | SENIOR HEALTH POLICY ANALYST |
| Public offices held: | No |
| Name: | SHARON SHOLZBERG-GRAY |
| Position title: | PRESIDENT AND CEO |
| Public offices held: | Yes |
| Name: | Graeme Wilkes |
| Position title: | Communications Advisor |
| Public offices held: | Yes |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Aboriginal Affairs and Northern Development Canada, Canadian Institute for Health Information, Canadian Institutes of Health Research (CIHR), Canadian Patient Safety Institute, Citizenship and Immigration Canada, Finance Canada (FIN), Health Canada (HC), Health Council of Canada, House of Commons Standing Committee on Finance, House of Commons Standing Committee on Health, Human Resources Development Canada (HRDC), Industry Canada, Members of the House of Commons, Ministry of Intergovernmental Affairs, Office of the Auditor General, Patented Medicine Prices Review Board (PMPRB), Prime Minister's Office (PMO), Privy Council Office (PCO), Public Health Agency of Canada (PHAC), Revenue Canada (RC), Senate Standing Committee on Social Affairs, Science and Technology, Statistics Canada (StatCan), Veterans Affairs Canada (VAC) | ||||||
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Grass-roots communication, Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format | ||||||
| Subject Matter: Areas of Concern: | Aboriginal Affairs, Constitutional Issues, Consumer Issues, Education, Employment and Training, Environment, Health, Immigration, Industry, Internal Trade, International Trade, Labour, Science and Technology, Taxation and Finance | ||||||
| Subject Matter: Retrospective: | 1) Health system employability issues, including the need for a national health human resources strategy or mechanism2) Pre-budget and budget consultations3) Pharmaceutical issues, including the elements of a proposed national pharmaceuticals strategy (Catastrophic Pharmaceutical Coverage, National Drug Formulary, Drug Approval Process, Evaluation of Real-World Drug Safety and Effectiveness, Purchasing Strategies, Optimal and Appropriate Use of Pharmaceuticals, Electronic Health Records and E-Prescribing, Access and Cost of Generic Drugs, Improving Cost-Effectiveness Analysis of Drugs) 4) Postsecondary education and training as they relate to the health system5) The 'fiscal imbalance' between the federal government and the provinces and territories6) Current challenges and future directions of the Canadian health system7) Health Canada's Blueprint for Renewal, including the Progressive Licensing Framework.8) Federal funding for the health system, including the Canada Health Transfer and the Equalization program9) Public-private issues, including the appropriate mix of public and private funding and delivery of health services in the Canadian health system10) Public health issues, including emergency preparedness, pandemic planning, health promotion and the management of chronic diseases11) Health system effectiveness, including issues of governance and accountability12) The federal role in Canada's health system, including the use of the federal spending power and national objectives13) The continuum of care, including the need for a mental health commission and expanded home- and continuing-care supports.14) Health system information technology, including an electronic health record15) Timely access to health services, including wait times, benchmarks and wait times guarantees16) The determinants of health, including investments in postsecondary education and the environment.17) Health research18) Taxation issues, including the GST rebate for medical services19) Patient safety and quality improvement20) Primary health care | ||||||
| Subject Matter: Prospective: | 1) Health human resources2) The federal budget3) Pharmaceutical issues, including the elements of a proposed national pharmaceuticals strategy (Catastrophic Pharmaceutical Coverage, National Drug Formulary, Drug Approval Process, Evaluation of Real-World Drug Safety and Effectiveness, Purchasing Strategies, Optimal and Appropriate Use of Pharmaceuticals, Electronic Health Records and E-Prescribing, Access and Cost of Generic Drugs, Improving Cost-Effectiveness Analysis of Drugs)4) Federal-provincial-territorial fiscal relations, including the Canada Health Transfer, Canada Social Transfer and Equalization program5) Public-private issues, including the appropriate mix of public and private funding and delivery of health services in the Canadian health system 6) Public health issues, including emergency preparedness, pandemic planning, health promotion and the management of chronic diseases7) Health system effectiveness, including issues of governance and accountability8) The federal role in Canada's health system, including the use of the federal spending power and national objectives9) The continuum of care, including the need for a mental health commission and expanded home- and continuing-care supports.10) Health system information technology, including an electronic health record11) Timely access to health services, including wait times, benchmarks and wait times guarantees12) The determinants of health, including investments in postsecondary education and the environment.13) Health research14) Taxation issues, including the GST rebate for medical services15) Patient safety and improvement16) Primary health care17) Aboriginal health | ||||||
Details Regarding the Identified Subject Matter
|
|||||||